Testing a New Glaucoma Surgery Implant to Prevent Low Eye Pressure
Part of Eyes & vision clinical trials.
This trial tests a tiny implant called Preserflo to treat glaucoma (high eye pressure) that hasn't been controlled with eyedrops. The surgery aims to lower pressure safely while avoiding complications like pressure that drops too low.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have primary open-angle, pseudoexfoliative, or pigmentary glaucoma that isn't controlled despite using multiple eyedrops
- Your eye pressure is too high or your vision is getting worse despite maximum eyedrop treatment
- You either had a previous glaucoma surgery that failed, or your doctor thinks you're at high risk of failure
- Your conjunctiva (clear membrane covering the white of your eye) is healthy with no scarring or previous surgery besides cataract removal
- You don't have severe systemic diseases, neovascular glaucoma, or other serious eye conditions besides cataracts
- Your corneal thickness is between 490 and 620 micrometers (measured by pachymetry)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies outcomes after certain minimally invasive glaucoma surgeries, including the Preserflo microshunt. It may help improve how safely and effectively glaucoma surgery is done, and how patients are followed afterward.
This trial tests two small drainage devices (PreserFlo and XEN stents) for glaucoma, sometimes with an amniotic membrane. The goal is to see which approach is safer and more effective at lowering eye pressure.
This trial compares three types of tissue grafts (sclera, pericardium, and cornea) used during certain glaucoma surgeries. It aims to find which graft works best to help control eye pressure.
This trial tests a new implant that releases medicine for glaucoma while you have cataract surgery. It may help lower eye pressure without using daily drops.
This trial compares two types of glaucoma drainage devices (Baerveldt and Paul) in people whose glaucoma is not well controlled with eye drops. It aims to find which device works better at lowering eye pressure and is safer.
This study tests a new gel implant (XEN63) to lower eye pressure in adults with open-angle glaucoma. It may be an option if your eye pressure remains high despite using eye drops, or if you can't tolerate the drops.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.